Demand for non-surgical procedures expected to rise 7.2% by 2012
A new report available from reportlinker.com shows that US demand for non-surgical procedures is likely to rise by 7.2% to a value of $9.4 billion in 2012.
The study shows that advances in technology paired with more astute marketing techniques will encourage rapid growth in the cosmeceutical market over the next few years.
Cosmeceutical products include skin-care products, injectables and a variety of wrinkle-relaxing products.
According to the research, an ageing population will cause an ever increasing demand for age-defying products, which will be enhanced by improved formulations.
Anti-ageing skin-care items are expected to achieve above average growth, while injectable products will experience the fastest growth with projected double-digit annual gains by 2012.
In addition, strong advances are expected to be made with botulinum toxin, the main ingredient in Botox, while dermal fillers, like Restylane and Juvederm, are also anticipated to benefit from the developments made to hyaluronic acid.
Perhaps unsurprisingly, the main competition faced by the non-surgical cosmeceutical industry is expected to come from alternative treatments like cosmetic surgery and laser resurfacing.
The news comes shortly after reports revealed that the market for non-surgical procedures like Botox is receiving a boost, as consumers seek cheaper and less-invasive aesthetic options during the global economic downturn.
A recent study presented to the American Society of Plastic Surgeons, for example, showed that while many surgeons were seeing a decreasing number of patients seeking breast augmentations and liposuction, demand for non-surgical procedures remained stable.
Tags: Add new tag, Botox, cosmeceutical products, cosmetic surgery, Dermal Fillers, Non surgical